The Zio® end-of-wear report is generated by an FDA-cleared, deep-learned algorithm that can detect 13 different types of arrhythmias, plus sinus rhythm and artifacts, and is curated and verified by Certified Cardiographic Technicians.16-19
Precision Brought to Your Practice
Zio® ECG monitors and the iRhythm end-to-end monitoring service deliver highly accurate, clinically actionable data1 to the world of cardiology and electrophysiology.
Streamlined cardiac monitoring made simple
Our goal is to help simplify the cardiac monitoring experience end to end. The iRhythm monitoring service helps you accomplish your program goals by delivering clinical accuracy while reducing the cost of care.2-6
Proven precision
The value of the iRhythm monitoring service has been demonstrated in over 100 original scientific research manuscripts.20
End-of-wear reports with 99% physician agreement15
- The algorithm can classify a broad range of distinct arrhythmias with high diagnostic performance similar to that of cardiologists17
- End-of-wear report provides a comprehensive analysis based on the full wear period16-19
- The Zio report provides you with a rich summary of clinically actionable cardiac events on the first page — and an easy-to-navigate deep dive for all the intricate details captured
Seamless EHR integration
Reduce staff burden, automate processes, and accelerate patient care pathways by integrating the iRhythm monitoring service directly into your electronic health record (EHR).
- Increased efficiency and standardized workflows
- Supports shift to value-based care
- Compatible with all major EHR systems21
Everything you need, all in one place
ZioSuite is an elegant, easy-to-use interface with smart productivity features that allow you to enroll, track and manage patients, and interpret reports with ease. Access the portal from your computer — or while on the go with the mobile app.22
- Patient registration
- Online interpretation
- Device tracking
- Account history management
Made exactly for patients like yours
Compared to Holter monitoring, the Zio LTCM device was well tolerated and allowed for longer continuous monitoring — resulting in an improvement in clinical accuracy, and a meaningful change in clinical management.5,6,23
The MyZio® patient app
Supports patients on their monitoring journey with convenient tracking, educational content, and more.
Full support
Questions about products, billing, or our services? We have you covered.
iRhythm offers dedicated support to help with issues like inventory management and customer satisfaction. We even have a specialized billing team to help manage revenue cycle questions and billing inquiries available 24/7/365.
WEB0185.01
- Data on file. iRhythm Technologies, 2022-2023.
- 99% of physicians agree with the comprehensive end-of-wear report. Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.
- Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25-34. doi.org/10.1016/j.ahj.2023.12.002
- A specified arrhythmia refers to an arrhythmia encounter diagnosis as per Hierarchical Condition Categories (HCC) 96.
- Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
- iRhythm LTCM service refers to Zio XT and Zio monitor service.
- Steinhubl et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation. JAMA. 2018;320(2):146-155. doi.org/10.1001/jama.2018.8102
- Analyzable time is based off 14-day prescription.
- Data on file. iRhythm Technologies, 2022.
- Barrett et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95.e11-95.e17. doi.org/10.1016/j.amjmed.2013.10.003
- Zio XT Clinical Reference Manual. iRhythm Technologies, 2019.
- Zio monitor Instructions for Use. iRhythm Technologies, 2023.
- Zio AT Clinical Reference Manual. iRhythm Technologies, 2022.
- Zio AT does not require battery changes or charging. Zio AT has wear time transmission limits and is contraindicated for critical care patients. Refer to the Zio AT Clinical Reference Manual for additional information.
- Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.
- Data on file. iRhythm Technologies, 2020.
- Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69. doi.org/10.1038/s41591-018-0268-3
- Deep-learned algorithm is only available in the United States, European Union, Switzerland, and United Kingdom.
- FDA 510K clearance, CE mark, and UKCA mark.
- Data on file. iRhythm Technologies, 2023.
- Baseline reports, daily reports, and transmission reports are not electronically transmitted from iRhythm to EHR systems. They are available in ZioSuite.
- ZioSuite Clinical Reference Manual. iRhythm Technologies, 2022.
- Rosenberg et al. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2012;36(3):328-333. doi.org/10.1111/pace.12053
- Data on file. iRhythm Technologies, 2017, 2023.
- The Zio monitor device should not be submerged in water. During a bath, keep the device above water. Please refer to the Zio monitor labeling instructions or Patient Guide for the full set of details.
WEB0012.1